Stomach cancer

Michael F. Price Memorial Grant from DeGregorio Family Foundation Awarded to Disrupt Cancer Stem Cells with Novel Experimental Drugs

Retrieved on: 
Friday, February 17, 2023
Esophageal cancer, Stomach cancer, De Gregorio, Grant, Patient, CSC, Maintenance, Cell, Metastasis, University, Research, Death, The, WNT, CSCS, Cancer, Doctor of Philosophy, Pharmaceutical industry, Vaccine

The Grant is named in memory of Michael F. Price, the noted value investor and philanthropist, who was an early supporter of the Foundation.

Key Points: 
  • The Grant is named in memory of Michael F. Price, the noted value investor and philanthropist, who was an early supporter of the Foundation.
  • Dr. Capobianco's research is dedicated to targeting cancer stem cell populations by dual inhibition of the Notch and Wnt pathways in upper GI cancers with novel experimental drugs.
  • It is widely accepted that these properties of cancer are driven by distinct populations of cells termed cancer stem cells (CSCs).
  • "We are honored to support this research into ways to destroy the cancer stem cell population in upper GI with novel experimental drugs," concluded Lynn DeGregorio, President and Founder.

EmergeOrtho Orthopedic Surgeon, Dr. Shadduck Leads Laparoscopic & Robotic Surgery Courses at Medical University Pleven

Retrieved on: 
Monday, February 13, 2023
Medical University Pleven, National meetings of the League of Communists of Yugoslavia, Hernia, Diagnosis, Stomach cancer, Gallbladder, Congress, Faculty, Medical school, Surgeon, Rostov State Medical University, Dentistry, Nursing, Industrial and Commercial Bank of China (Asia)

DURHAM, N.C., Feb. 13, 2023 /PRNewswire/ -- EmergeOrtho––Triangle Region's Dr. Phillip Shadduck , general surgeon, gastrointestinal (GI) and hernia surgeon , helped conduct training courses for young doctors in laparoscopic and robotic surgery at the Pleven Medical University in Bulgaria.

Key Points: 
  • DURHAM, N.C., Feb. 13, 2023 /PRNewswire/ -- EmergeOrtho––Triangle Region's Dr. Phillip Shadduck , general surgeon, gastrointestinal (GI) and hernia surgeon , helped conduct training courses for young doctors in laparoscopic and robotic surgery at the Pleven Medical University in Bulgaria.
  • Taking place on Oct. 6, 2022, the laparoscopic and robotic surgery training course for residents immediately preceded the 18th Bulgarian National Congress of Surgery program on Oct 7, 2022.
  • At the XVIII Bulgarian National Congress of Surgery meeting, also hosted at the Medical University in Pleven, Bulgaria, Dr Shadduck moderated a session of presentations by US faculty.
  • After the laparoscopic and robotic surgery training course, Dr. Shadduck presented certificates to the young specialists from the university.

The Global Cancer Biomarkers Market to Upsurge at a Tremendous CAGR of ~14% by 2027 | DelveInsight

Retrieved on: 
Monday, February 13, 2023
Medicine, Colon, Smoking, Abbott Laboratories, Agilent Technologies, Cancer, Neurology, Quest Diagnostics, OncoDNA, Merck Millipore, Lung cancer, Sysmex Corporation, Collection, Minerva Surgical, Inc. v. Hologic, Inc., Roche, Biomarker, Emergency, Oncology, PerkinElmer, Prostate cancer, FDA, Growth, Illumina, Inc., Prevalence, AstraZeneca, US Foods, LAS, R, BD, Helmy Eltoukhy, TK1, United Kingdom, Immunotherapy, MBC, Diagnosis, Breast cancer, Myriad Genetics, Data analysis, Patient, Research, Cell proliferation, Risk, Serum, COVID-19, NSCLC, Stomach cancer, PD-L1, QIAGEN, Siemens Healthineers, Exact sciences, Prognosis, Dietary supplement, Oil, Pharmaceutical industry, Medical imaging

LAS VEGAS, Feb. 13, 2023 /PRNewswire/ -- DelveInsight's Cancer Biomarkers Market Insights report provides the current and forecast market analysis, individual leading cancer biomarkers companies' market shares, challenges, cancer biomarkers market drivers, barriers, and trends, and key cancer biomarkers companies in the market.

Key Points: 
  • LAS VEGAS, Feb. 13, 2023 /PRNewswire/ -- DelveInsight's Cancer Biomarkers Market Insights report provides the current and forecast market analysis, individual leading cancer biomarkers companies' market shares, challenges, cancer biomarkers market drivers, barriers, and trends, and key cancer biomarkers companies in the market.
  • As per DelveInsight estimates, North America is anticipated to dominate the global cancer biomarkers market during the forecast period.
  • To read more about the latest highlights related to the cancer biomarkers market, get a snapshot of the key highlights entailed in the Global Cancer Biomarkers Market Report
    Cancer biomarkers are biological molecules that aid in the detection of cancer in patients.
  • To know more about why North America is leading the market growth in the cancer biomarkers market, get a snapshot of the Cancer Biomarkers Market Outlook
    One of the major factors driving the growth of the cancer biomarkers market is the global increase in the prevalence of various types of cancer.

The Global Cancer Biomarkers Market to Upsurge at a Tremendous CAGR of ~14% by 2027 | DelveInsight

Retrieved on: 
Monday, February 13, 2023
Medicine, Colon, Smoking, Abbott Laboratories, Agilent Technologies, Cancer, Neurology, Quest Diagnostics, OncoDNA, Merck Millipore, Lung cancer, Sysmex Corporation, Collection, Minerva Surgical, Inc. v. Hologic, Inc., Roche, Biomarker, Emergency, Oncology, PerkinElmer, Prostate cancer, FDA, Growth, Illumina, Inc., Prevalence, AstraZeneca, US Foods, LAS, R, BD, Helmy Eltoukhy, TK1, United Kingdom, Immunotherapy, MBC, Diagnosis, Breast cancer, Myriad Genetics, Data analysis, Patient, Research, Cell proliferation, Risk, Serum, COVID-19, NSCLC, Stomach cancer, PD-L1, QIAGEN, Siemens Healthineers, Exact sciences, Prognosis, Dietary supplement, Oil, Pharmaceutical industry, Medical imaging

LAS VEGAS, Feb. 13, 2023 /PRNewswire/ -- DelveInsight's Cancer Biomarkers Market Insights report provides the current and forecast market analysis, individual leading cancer biomarkers companies' market shares, challenges, cancer biomarkers market drivers, barriers, and trends, and key cancer biomarkers companies in the market.

Key Points: 
  • LAS VEGAS, Feb. 13, 2023 /PRNewswire/ -- DelveInsight's Cancer Biomarkers Market Insights report provides the current and forecast market analysis, individual leading cancer biomarkers companies' market shares, challenges, cancer biomarkers market drivers, barriers, and trends, and key cancer biomarkers companies in the market.
  • As per DelveInsight estimates, North America is anticipated to dominate the global cancer biomarkers market during the forecast period.
  • To read more about the latest highlights related to the cancer biomarkers market, get a snapshot of the key highlights entailed in the Global Cancer Biomarkers Market Report
    Cancer biomarkers are biological molecules that aid in the detection of cancer in patients.
  • To know more about why North America is leading the market growth in the cancer biomarkers market, get a snapshot of the Cancer Biomarkers Market Outlook
    One of the major factors driving the growth of the cancer biomarkers market is the global increase in the prevalence of various types of cancer.

Global Reduced Salt Food Products Market Report 2022 to 2028: Featuring General Mills, Nestle, PepsiCo and Hormel Foods Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, January 20, 2023
Food, Beverage, Retail, Intussusception (medical disorder), Stomach cancer, Sodium chloride, Stroke, Lethargy, Meat, Kidney disease, Health, Hyponatremia, Blood, Vegetable, Cell, Heart failure, Water, COVID-19, Mental toughness, Egg, Meal, Cooking, Market, Osteoporosis, Eating, World Health Organization, Diet, Drinking, Risk, Sodium, Poultry, Salt, Dietary supplement

The "Global Reduced Salt Food Products Market Size, Share & Industry Trends Analysis Report by Type, Distribution Channel, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Reduced Salt Food Products Market Size, Share & Industry Trends Analysis Report by Type, Distribution Channel, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Global Reduced Salt Food Products Market size is expected to reach $431.1 billion by 2028, rising at a market growth of 5.0% CAGR during the forecast period.
  • It is naturally present in foods like vegetables and eggs, as well as being a significant part of table salt (sodium chloride).
  • The reduced salt food products market was also impacted due to the closure of manufacturing facilities.

CARsgen Announces Collaboration Agreement to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer

Retrieved on: 
Tuesday, January 31, 2023
Safety, IND, Gastrointestinal cancer, IHC, Pancreatic cancer, Collection, Stomach, Stomach cancer, CAR, PD-L1, Roche, Patient, Pharmaceutical industry

As part of the clinical collaboration, CARsgen's proprietary CLDN18.2 IHC test kit, which has showed excellent specificity and sensitivity profiles, will be applied to evaluate CLDN18.2 expression in the gastric cancer patients.

Key Points: 
  • As part of the clinical collaboration, CARsgen's proprietary CLDN18.2 IHC test kit, which has showed excellent specificity and sensitivity profiles, will be applied to evaluate CLDN18.2 expression in the gastric cancer patients.
  • The co-funded study of AB011 in combination with atezolizumab will be conducted as part of Roche's Morpheus Platform.
  • CLDN18.2 is a promising therapeutic target for the treatment of CLDN18.2 positive solid tumors, including gastric cancer, pancreatic cancer, etc.
  • Through this collaboration, we are excited to evaluate the combination of AB011 and atezolizumab which can potentially bring greater clinical benefits to gastric cancer patients."

The Worldwide Reduced Salt Food Products Industry is Expected to Reach $431.1 Billion by 2028

Retrieved on: 
Sunday, January 22, 2023
Intussusception (medical disorder), Stomach cancer, Sodium chloride, Stroke, Lethargy, Meat, Kidney disease, Health, Hyponatremia, Blood, Vegetable, Cell, Heart failure, Water, Food, COVID-19, Mental toughness, Egg, Meal, Cooking, Market, Osteoporosis, Eating, World Health Organization, Diet, Drinking, Risk, Sodium, Poultry, Salt, Dietary supplement

The "Global Reduced Salt Food Products Market Size, Share & Industry Trends Analysis Report by Type, Distribution Channel, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Reduced Salt Food Products Market Size, Share & Industry Trends Analysis Report by Type, Distribution Channel, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Global Reduced Salt Food Products Market size is expected to reach $431.1 billion by 2028, rising at a market growth of 5.0% CAGR during the forecast period.
  • The reduced salt food products market was also impacted due to the closure of manufacturing facilities.
  • As a result, rising consumer awareness of the negative effects of high sodium intake as well as a growing desire for nutrient-dense, healthier food products is driving the reduced salt food products market.

Global Stoma or Ostomy Care Market Report to 2029 - Featuring 3M, Alcare, B. Braun Melsungen and Coloplast Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 19, 2023
Health, Oncology, Medical Devices, Projection, Colostomy, IBD, Cancer, Ileostomy, Stoma, Hospital, Stomach cancer, Research report, Patient, Prevalence, Environment, Population growth, Medicine, Health insurance

However, the ostomy bag irritation and additional complications, increasing use of alternative therapies and, ostomy-related difficulties are expected to restrain the market growth.

Key Points: 
  • However, the ostomy bag irritation and additional complications, increasing use of alternative therapies and, ostomy-related difficulties are expected to restrain the market growth.
  • On the basis of type, the market is bifurcated into ostomy accessories and ostomy bags.
  • Based on end users, the market is categorized into ambulatory surgical centers, hospitals and specialty clinics, and home care settings.
  • This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including surgery type, product, and end users from 2022-2029.

$1,361.9 Prescription Drugs Markets - Global Forecasts from 2022 to 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 12, 2023
Biotechnology, Pharmaceutical, Health, Disease, Cardiovascular disease, Schizophrenia, Overalls, Stomach cancer, United Kingdom, Prostate cancer, World Health Organization, Skin cancer, Hypertension, Cancer, Blood, COVID-19, Heart, Lung cancer, Colorectal cancer, Death, Tablet, Degenerative disease, Health, Teva Pharmaceuticals, Conditional sentence, Mycophenolic acid, Infection, Plasma protein binding, Risk, Growth, Patient, Prevalence, Diabetes, Urbanization, Coronavirus, Disability, Research, Mortality, Disorder, CDC, Alzheimer's disease, Incidence, Breast cancer, Investment, Obesity, Dietary supplement, Pharmaceutical industry, Generic drug, Teva, Ziprasidone

The "Global Prescription Drugs Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Prescription Drugs Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The increasing number of chronic diseases worldwide is further continuing to increase the sales of prescription drugs in the forecast period.
  • The market for prescription drugs will further proliferate with the research and development investments among companies for the manufacturing of innovative drugs.
  • The developed regions of the world, particularly, North America, are projected to hold a significant market share in the global prescription drug market.

Global Non-invasive Cancer Diagnosis Market Analysis and Forecasts 2022-2028: Focus on Clinical Chemistry, Immunochemistry/Immunoassay, Molecular Diagnostics, and Other Clinical Instruments - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023
Biotechnology, Health, Oncology, Medical Devices, News, Novartis, Stomach cancer, Prostate cancer, World Health Organization, Lung cancer, WHO, England, Government, GE Healthcare, Colon, Cancer, NHS England, Death, Woman, Diagnosis, Identity management, Growth, New Jersey Department of Health, Patient, Prevalence, Cancer Research UK, Quest Diagnostics, LabCorp, Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., Public Health England, Breast cancer, Medical device, Medical imaging, Marketing

A non-invasive cancer diagnosis is a method of detecting cancer conditions with just a small incision in the body.

Key Points: 
  • A non-invasive cancer diagnosis is a method of detecting cancer conditions with just a small incision in the body.
  • The most common new cases of cancer in 2020 include breast cancer (2.26 million), lung cancer (2.21 million), colon and rectum cancer (1.93 million), prostate cancer (1.41 million), stomach cancer (1.09 million), and others.
  • This significant number of cancer cases has shifted the global attention towards the adoption of early detection and diagnosis techniques for cancer.
  • Asia-Pacific is anticipated to hold a considerable growth in the global non-invasive cancer diagnosis market.